We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Predictors of GBV-C infection among patients referred for renal transplantation.
- Authors
Murthy; Muerhoff, A. Scott; Desai, Suresh M.; Natov, Svetlozar N.; Bouthot, Beth A.; Ruthazer, Robin; Schmid, Christopher H.; Levey, Andrew S.; Mushahwar, Isa K.; Pereira, Brian J.G.
- Abstract
Predictors of GBV-C infection among patients referred for renal transplantation. The etiology of liver disease remains unknown in about 4 to 23% of dialysis patients and 10 to 16% of renal transplant recipients. A search for other causative agents of liver disease led to the discovery of the GB group of viruses. We studied the association between the presence of GB virus C (GBV-C) infection, known risk factors for parenterally-transmitted infections and history or laboratory evidence of liver disease among end-stage renal disease (ESRD) patients referred for renal transplantation to the New England Organ Bank, MA. Stored sera from patients on the renal transplantation waiting list between November 1986 and June 1990 were tested for antibody to hepatitis C virus (HCV). Sera were available in 1544 of 3243 (48%) patients, and anti-HCV was detected by ELISA3 in 287 (19%). All 287 anti-HCV positive patients formed the anti-HCV positive cohort and 286 randomly selected anti-HCV negative patients formed the anti-HCV negative cohort (573 patients overall). Additional sera were available for GBV-C RNA testing in 465 of 573 (81%) patients, and GBV-C RNA was detected by RT-PCR in 146. The overall extrapolated prevalence of serum GBV-C RNA was 29%. The prevalence of serum GBV-C RNA among anti-HCV positive patients (35%) was not significantly different from that among anti-HCV negative patients (29%; P = 0.22). In a univariate analysis, compared to patients without GBV-C RNA, patients with serum GBV-C RNA were younger [odds ratio (OR) 0.98 per year of age, P = 0.01], had a lower proportion of males (OR 0.64, P = 0.03), lower proportion of patients with diabetes mellitus (OR 0.44, P = 0.01), higher proportion of patients with a previous transplantation (OR 1.53, P = 0.04), longer duration of dialysis at the time of enrollment (OR 1.004 per month on dialysis, P = 0.03), and a higher proportion of patients with history of transfusions (OR 4.58, P = 0.01). Serum GBV-C RNA was...
- Subjects
MASSACHUSETTS; UNITED States; SARIN; KIDNEY diseases; TRANSPLANTATION of organs, tissues, etc.
- Publication
Kidney International, 1998, Vol 53, Issue 6, p1769
- ISSN
0085-2538
- Publication type
Article
- DOI
10.1046/j.1523-1755.1998.00910.x